These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38452616)

  • 61. Multigene and Drug Interaction Approach for Tamoxifen Metabolite Patterns Reveals Possible Involvement of CYP2C9, CYP2C19, and ABCB1.
    Powers JL; Buys SS; Fletcher D; Melis R; Johnson-Davis KL; Lyon E; Malmberg EM; McMillin GA
    J Clin Pharmacol; 2016 Dec; 56(12):1570-1581. PubMed ID: 27198207
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Genetic Polymorphism of Drug-Metabolizing Enzymes CYP2C9 and CYP2C19 in Moroccan Population.
    Afilal D; Basselam MA; Brakez Z; Chouham S; Brehm A; Izaabel EH
    Genet Test Mol Biomarkers; 2017 May; 21(5):298-304. PubMed ID: 28282224
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differential expression and function of CYP2C isoforms in human intestine and liver.
    Läpple F; von Richter O; Fromm MF; Richter T; Thon KP; Wisser H; Griese EU; Eichelbaum M; Kivistö KT
    Pharmacogenetics; 2003 Sep; 13(9):565-75. PubMed ID: 12972955
    [TBL] [Abstract][Full Text] [Related]  

  • 64. LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses.
    Cusinato DAC; Filgueira GCO; Rocha A; Cintra MACT; Lanchote VL; Coelho EB
    J Pharm Biomed Anal; 2019 Feb; 164():430-441. PubMed ID: 30445356
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Toward Xeno-Free Differentiation of Human Induced Pluripotent Stem Cell-Derived Small Intestinal Epithelial Cells.
    Saari J; Siddique F; Korpela S; Mäntylä E; Ihalainen TO; Kaukinen K; Aalto-Setälä K; Lindfors K; Juuti-Uusitalo K
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163236
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization of human small intestinal cytochromes P-450.
    Zhang QY; Dunbar D; Ostrowska A; Zeisloft S; Yang J; Kaminsky LS
    Drug Metab Dispos; 1999 Jul; 27(7):804-9. PubMed ID: 10383924
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficient Generation of Small Intestinal Epithelial-like Cells from Human iPSCs for Drug Absorption and Metabolism Studies.
    Negoro R; Takayama K; Kawai K; Harada K; Sakurai F; Hirata K; Mizuguchi H
    Stem Cell Reports; 2018 Dec; 11(6):1539-1550. PubMed ID: 30472010
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparative metabolism of aschantin in human and animal hepatocytes.
    Lee MS; Shim HJ; Cho YY; Lee JY; Kang HC; Song IS; Lee HS
    Arch Pharm Res; 2024 Feb; 47(2):111-126. PubMed ID: 38182943
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Further assessment of 17alpha-ethinyl estradiol as an inhibitor of different human cytochrome P450 forms in vitro.
    Chang SY; Chen C; Yang Z; Rodrigues AD
    Drug Metab Dispos; 2009 Aug; 37(8):1667-75. PubMed ID: 19454483
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Short-term fasting alters cytochrome P450-mediated drug metabolism in humans.
    Lammers LA; Achterbergh R; de Vries EM; van Nierop FS; Klümpen HJ; Soeters MR; Boelen A; Romijn JA; Mathôt RA
    Drug Metab Dispos; 2015 Jun; 43(6):819-28. PubMed ID: 25795462
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Use of Human Plasma Samples to Identify Circulating Drug Metabolites that Inhibit Cytochrome P450 Enzymes.
    Eng H; Obach RS
    Drug Metab Dispos; 2016 Aug; 44(8):1217-28. PubMed ID: 27271369
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Regional Transcriptomics and Proteomics of Pharmacokinetics-Related Genes in Human Intestine.
    Murata M; Fujioka H; Yokota J; Okada K; Yamashita T; Hirayama D; Kawakami K; Morinaga G; Saito A; Nakase H; Kishimoto W; Mizuguchi H
    Mol Pharm; 2023 Jun; 20(6):2876-2890. PubMed ID: 37132462
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples.
    Yamazaki H; Inoue K; Shaw PM; Checovich WJ; Guengerich FP; Shimada T
    J Pharmacol Exp Ther; 1997 Nov; 283(2):434-42. PubMed ID: 9353355
    [TBL] [Abstract][Full Text] [Related]  

  • 74. New Maintenance Culture Method for Intestinal Stem Cells Derived from Human Induced Pluripotent Stem Cells.
    Mizuno S; Jinnoh Y; Arita A; Qiu S; Hashita T; Hori E; Iwao T; Matsunaga T
    Biol Pharm Bull; 2024; 47(1):120-129. PubMed ID: 38171772
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In Vitro Human Cell-Based Experimental Models for the Evaluation of Enteric Metabolism and Drug Interaction Potential of Drugs and Natural Products.
    Li AP
    Drug Metab Dispos; 2020 Oct; 48(10):980-992. PubMed ID: 32636209
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Results from Drug-Drug Interaction Studies In Vitro and In Vivo Investigating the Effect of Finerenone on the Pharmacokinetics of Comedications.
    Heinig R; Gerisch M; Bairlein M; Nagelschmitz J; Loewen S
    Eur J Drug Metab Pharmacokinet; 2020 Aug; 45(4):433-444. PubMed ID: 32125665
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The influence of temperature on the metabolic activity of CYP2C9, CYP2C19, and CYP3A4 genetic variants
    Kojima M; Machida K; Cho S; Watanabe D; Seki H; Shimoji M; Imaoka A; Yamazaki H; Guengerich FP; Nakamura K; Yamamoto K; Akiyoshi T; Ohtani H
    Xenobiotica; 2023 May; 53(5):357-365. PubMed ID: 37584614
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human Enterocytes as an In Vitro Model for the Evaluation of Intestinal Drug Metabolism: Characterization of Drug-Metabolizing Enzyme Activities of Cryopreserved Human Enterocytes from Twenty-Four Donors.
    Ho MD; Ring N; Amaral K; Doshi U; Li AP
    Drug Metab Dispos; 2017 Jun; 45(6):686-691. PubMed ID: 28396528
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patients.
    Lanchote VL; Almeida R; Barral A; Barral-Netto M; Marques MP; Moraes NV; da Silva AM; Souza TM; Suarez-Kurtz G
    Br J Clin Pharmacol; 2015 Nov; 80(5):1160-8. PubMed ID: 25940755
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An improved LC-MS/MS method for simultaneous evaluation of CYP2C9, CYP2C19, CYP2D6 and CYP3A4 activity.
    Sreevatsav Adiraju SK; Shekar K; Fraser JF; Smith MT; Ghassabian S
    Bioanalysis; 2018 Oct; 10(19):1577-1590. PubMed ID: 30226084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.